We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Study Could Trigger Additional Vioxx Lawsuits
New Study Could Trigger Additional Vioxx Lawsuits
May 4, 2006
A newly published study that suggests an increased adverse event risk with the short-term use of Merck’s arthritis drug Vioxx (rofecoxib) could cause a resurgence in lawsuits related to the medication, according to an attorney representing Vioxx users.